Article Versions Notes

Thalen M, Debrie A-S, Coutte L, Raze D, Solovay K, Rubin K, Mielcarek N, Locht C. Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1. Vaccines. 2020; 8(3):523. https://doi.org/10.3390/vaccines8030523

Thalen, Marcel, Anne-Sophie Debrie, Loic Coutte, Dominique Raze, Ken Solovay, Keith Rubin, Nathalie Mielcarek, and Camille Locht. 2020. "Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1" Vaccines 8, no. 3: 523. https://doi.org/10.3390/vaccines8030523

Thalen, M., Debrie, A. -S., Coutte, L., Raze, D., Solovay, K., Rubin, K., Mielcarek, N., & Locht, C. (2020). Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1. Vaccines, 8(3), 523. https://doi.org/10.3390/vaccines8030523